Clinical Data Platform News Today

Laife Reply, a company within the Reply Group focused on using AI, Big Data and Machine Learning to innovate preventive healthcare and treatment processes has developed, in collaboration with IEO ,...

Manual and Guideline in English on World about Health and Epidemic; published on 28 Apr 2023 by WHO

SugoSure targets patients with type 2 diabetes below 65 years old.

Early studies indicate the strain may cause less severe COVID-19 symptoms compared to its precursor, the delta variant.

WHO Director General Tedros Adhanom Ghebreyesus said that there is some evidence that shows that Omicron variant causes milder disease than Delta strain, but it’s still too early to be definitive.

WHO Director General Tedros Adhanom Ghebreyesus said that there is some evidence that shows that Omicron variant causes milder disease than Delta strain, but it’s still too early to be definitive.

+ activeFrame.title + ); $(".fotorama-caption").addClass("add_caption"); $(".fotorama-caption").removeClass("remove_caption"); } else { // alert("hide div"); $(".fotorama-caption").addClass("remove_caption"); $(".fotorama-caption").removeClass("add_caption"); } }) .fotorama(); HIV infection increases risk of severe, critical COVID-19, WHO warns Sunday, July 18, 2021 A new World Health ...

More Than 100 Companies Adopt eClinical Solutions’ elluminate® Clinical Data Platform to Increase Clinical Trial Efficiency Share Article Life sciences technology platform provider builds on demand for modern data pipelines, faster review and analytics and expands senior leadership "With technology platforms like elluminate, we can build on the industry-wide advances made during the pandemic, help manage the data streams coming from decentralized trials and deliver new and important treatmen...